CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The population of China in 2014 was approximately 1.37 billion, having grown at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008. The country’s increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical industry, which was estimated to be worth $106.5 billion in 2008 and is projected to reach $1,637.3 billion by 2020, at a CAGR of 25.6%. Approximately 95% of China’s population has healthcare coverage. Improvements in drug safety and quality; a shorter drug registration timeline; the elimination of price caps by the government; a more transparent system for the approval of drugs and medical instruments; and an IPR regime are driving innovation in the pharmaceutical sector. These changes encourage foreign Multinational Companies (MNC) to invest in China. The Chinese medical device market is the second largest in Asia, valued at $27.7 billion in 2014 and projected to grow at a CAGR of 10.6% to an estimated $50.8 billion in 2020. These growth trends can be primarily attributed to the following causes:
Sedentary lifestyles leading to a high chronic disease burden.
The accessibility of healthcare professionals in the remote areas of the county.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in China, and includes:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: GlaxoSmithKline, Pfizer, AstraZeneca, Harbin Pharmaceutical Group, Tianjin Tasly Pharmaceutical Group, Jiangsu Hengru Medicine, Qilu Pharmaceutical and CSPC Pharmaceutical and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Philips, Medtronic and F. Hoffman La Roche
Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
Develop business strategies by understanding the trends shaping and driving China’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect China’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
Identify, understand, and capitalize on the opportunities and challenges in China’s healthcare market
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.